Brendan Kelly

Fondateur chez

A2a Pharmaceuticals, Inc.

Finance

Consumer Services

Technology Services

Profil

Brendan is a Vice President at Lightstone Ventures evaluating opportunities in the biopharmaceutical sector.
Brendan has a background in medicinal chemistry and computational drug discovery research, and life sciences strategy.
Prior to Lightstone, Brendan was Director of New Product Planning at Q32 Bio, where he helped to define value propositions and commercial strategy for the company’s lead assets and discovery platform.
Brendan was previously a life sciences strategy consultant at L.E.K.
Consulting, working on projects across therapeutic areas, modalities and technologies, including pipeline optimization, go-to-market strategies, BD and M&A due diligence.
Brendan’s research at Stanford Computer Science, University of Toronto and Trinity College Dublin focused on computational methods of small molecule drug discovery for oncology and neuroscience targets.
With his background in research and strategy, Brendan is keenly Interested in the intersection of innovative science, company formation and strategy, particularly in the pursuit of new therapeutics for patients in need.

Postes actifs de Brendan Kelly

Sociétés	Poste	Début
A2a Pharmaceuticals, Inc. A2a Pharmaceuticals, Inc. Packaged SoftwareTechnology Services Develops proprietary computational systems and new therapeutics that serve highly unmet patient needs	Fondateur	-
LSV CAPITAL MANAGEMENT LLC LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, biotech, and medtech sectors. It provides financing for seed, early, and later stage capital requirements.	Private Equity Investor	01/11/2021

Tous les postes actifs de Brendan Kelly

Anciens postes connus de Brendan Kelly

Sociétés	Poste	Fin
Q32 Bio, Inc. Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform	Corporate Officer/Principal	01/11/2021
OS Fund LLC OS Fund LLC Investment ManagersFinance OS Fund invests in companies located in the United States. The firm targets companies operating in the fields of genomics, synthetic biology, computationally derived therapeutics, advanced materials and diagnostics. It provides financing for early stage capital requirements.	Consultant / Advisor	01/11/2021

Voir l'expérience en détail de Brendan Kelly

Formation de Brendan Kelly

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Brendan Kelly

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	5
Trinity College Dublin Trinity College Dublin Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
LSV CAPITAL MANAGEMENT LLC LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, biotech, and medtech sectors. It provides financing for seed, early, and later stage capital requirements.	Finance
OS Fund LLC OS Fund LLC Investment ManagersFinance OS Fund invests in companies located in the United States. The firm targets companies operating in the fields of genomics, synthetic biology, computationally derived therapeutics, advanced materials and diagnostics. It provides financing for early stage capital requirements.	Finance
A2a Pharmaceuticals, Inc. A2a Pharmaceuticals, Inc. Packaged SoftwareTechnology Services Develops proprietary computational systems and new therapeutics that serve highly unmet patient needs	Technology Services
Q32 Bio, Inc. Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform	Health Technology